These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25618280)

  • 1. Examining the ethical boundaries of harm reduction: from addictions to general psychiatry.
    Lev-Ran S; Nitzan U; Fennig S
    Isr J Psychiatry Relat Sci; 2014; 51(3):175-80. PubMed ID: 25618280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobacco harm reduction: a call to address the ethical dilemmas.
    Fox BJ; Cohen JE
    Nicotine Tob Res; 2002; 4 Suppl 2():S81-7. PubMed ID: 12573170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should healthcare professionals sometimes allow harm? The case of self-injury.
    Sullivan PJ
    J Med Ethics; 2017 May; 43(5):319-323. PubMed ID: 28183785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is groin injecting an ethical boundary for harm reduction?
    Miller PG; Lintzeris N; Forzisi L
    Int J Drug Policy; 2008 Dec; 19(6):486-91. PubMed ID: 18024001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtue ethics as an alternative to deontological and consequential reasoning in the harm reduction debate.
    Christie T; Groarke L; Sweet W
    Int J Drug Policy; 2008 Feb; 19(1):52-8. PubMed ID: 18226518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ethical dilemmas of contemporary psychiatry].
    Filaković P; Pozgain I
    Lijec Vjesn; 2008; 130(1-2):26-30. PubMed ID: 18589640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating Addictions: Harm Reduction in Clinical Care and Prevention.
    Drucker E; Anderson K; Haemmig R; Heimer R; Small D; Walley A; Wood E; van Beek I
    J Bioeth Inq; 2016 Jun; 13(2):239-49. PubMed ID: 27112489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engagement as an ethical imperative in harm reduction involving at-risk youth.
    Paterson BL; Panessa C
    Int J Drug Policy; 2008 Feb; 19(1):24-32. PubMed ID: 18164609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strengthening drug policy and practice through ethics engagement: an old challenge for a new harm reduction.
    Irwin KS; Fry CL
    Int J Drug Policy; 2007 Mar; 18(2):75-83. PubMed ID: 17689348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In support of abstinence. Harm reduction ultimately fails to improve the quality of life for people with addictions.
    Tieman D
    Behav Healthc; 2007 Jul; 27(7):45. PubMed ID: 18027622
    [No Abstract]   [Full Text] [Related]  

  • 11. Contingencies of the will: Uses of harm reduction and the disease model of addiction among health care practitioners.
    Szott K
    Health (London); 2015 Sep; 19(5):507-22. PubMed ID: 25394654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moral frameworks, ethical engagement and harm reduction: commentary on 'Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics' by C. L. Fry, C. Treloar & L. Maher.
    Keane H
    Drug Alcohol Rev; 2005 Nov; 24(6):551-2. PubMed ID: 16361212
    [No Abstract]   [Full Text] [Related]  

  • 13. Applied communitarian ethics for harm reduction: promoting a dialogue within the field.
    Fry C; Treloar C; Maher L
    Drug Alcohol Rev; 2007 Sep; 26(5):553-5. PubMed ID: 17701519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco harm reduction strategies: the case for physical activity.
    deRuiter W; Faulkner G
    Nicotine Tob Res; 2006 Apr; 8(2):157-68. PubMed ID: 16766410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engaging the values-based ethical dilemmas in harm minimization: a response to Weatherburn.
    Fry CL; Irwin K
    Addiction; 2009 May; 104(5):862-3; author reply 863-4. PubMed ID: 19413798
    [No Abstract]   [Full Text] [Related]  

  • 16. The ethical, legal and social context of harm reduction.
    Pauly B; Goldstone I; McCall J; Gold F; Payne S
    Can Nurse; 2007 Oct; 103(8):19-23. PubMed ID: 17990401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Patients and caregivers in the treatment of addictions].
    Coppel A
    Rev Infirm; 2018 Jan; 67(237):16-18. PubMed ID: 29331185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harm reduction: Philosophical drivers of conceptual tensions and ways forward.
    Jiao S
    Nurs Inq; 2019 Apr; 26(2):e12286. PubMed ID: 30773745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: Similarities and Differences Between Harm-Reduction and Substitute Addiction-- Implications for the Health Professions.
    Sussman S; Sinclair DL; Clifasefi SL; Collins SE
    Eval Health Prof; 2024 Mar; 47(1):75-80. PubMed ID: 38247290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on harm-reduction policy and intervention research.
    Marlatt GA; Witkiewitz K
    Annu Rev Clin Psychol; 2010; 6():591-606. PubMed ID: 20192791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.